首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
【2h】

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.

机译:血管紧张素转化酶抑制作用改善了大分子和水的肾小球滤过并减轻了大鼠的肾小球损伤。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effect of enalapril on glomerular hemodynamics and permselectivity and on subsequent sclerosis was studied in male MWF/Ztm rats which spontaneously develop proteinuria and glomerular structural damage. Untreated group 1 and enalapril-treated group 2 (50 mg/liter, in the drinking water) underwent micropuncture studies after 2 mo of observation. After the same period of treatment, group 3 (untreated) and group 4 (enalapril treated) were used for determination of whole-kidney function and neutral dextran clearances. Group 5 (untreated) and group 6 (enalapril treated) were followed for an additional 4 mo and used for kidney function and morphological studies. Enalapril significantly lowered systolic blood pressure, which was elevated in untreated groups, and significantly reduced proteinuria (295 +/- 64 vs. 128 +/- 24 mg/24 h by the end of the study). Despite the reduced renal perfusion pressure, whole-kidney glomerular filtration rate was higher in enalapril-treated than in untreated rats (0.96 +/- 0.14 vs. 0.81 +/- 0.10 ml/min, P less than 0.05) as was the single nephron glomerular filtration rate (54 +/- 7.1 vs. 46 +/- 4.0 nl/min, P less than 0.05). The single glomerular afferent plasma flow was comparable in both groups. Enalapril reduced mean glomerular capillary hydraulic pressure from the normal value of 51 +/- 1 mmHg (untreated rats) to a value lower than normal (44 +/- 1 mmHg, P less than 0.001). These hemodynamic changes were associated with a significant reduction in afferent (approximately 23%) and efferent (approximately 26%) arteriolar resistance. The mean ultrafiltration coefficient was two times higher in the enalapril (0.126 +/- 0.027 nl/s per mmHg) than in the untreated group (0.061 +/- 0.023 nl/s per mmHg). The clearance of dextran macromolecules relative to that of inulin was significantly reduced for all molecular sizes studied (26-64 A) in enalapril-treated vs. untreated rats. Theoretical analysis of dextran fractional clearances using a heteroporous model of neutral solute transport across the glomerular capillary wall indicated that enalapril affected glomerular membrane size selective properties, reducing uniformly the radius of hypothetical membrane pores. Enalapril treatment also significantly limited (P less than 0.01) the development of glomerular structural lesions (mean percentage of sclerotic glomeruli was 4.2 +/- 3.5% [treated] vs. 28 +/- 15% [untreated] rats at the end of the study) as well as tubulo-interstitial damage. These results suggest that the protective effect of enalapril on the development of proteinuria and glomerular sclerosis in this model is due to its property of ameliorating size selectivity and hydraulic permeability of the glomerular capillaries.
机译:在雄性自发性蛋白尿和肾小球结构损害的MWF / Ztm雄性大鼠中研究了依那普利对肾小球血流动力学和通透性以及随后的硬化的影响。观察2个月后,未治疗的组1和依那普利治疗的组2(50 mg / L,在饮用水中)进行微穿刺研究。在相同的治疗时间后,将第3组(未治疗)和第4组(接受依那普利治疗)用于测定全肾功能和中性葡聚糖清除率。第5组(未治疗)和第6组(接受依那普利治疗)再随访4个月,用于肾功能和形态学研究。依那普利显着降低了收缩压,该收缩压在未经治疗的组中升高,并显着降低了蛋白尿(在研究结束时为295 +/- 64 vs. 128 +/- 24 mg / 24 h)。尽管肾灌注压降低,依那普利治疗组的全肾小球滤过率仍高于未治疗组(0.96 +/- 0.14 vs. 0.81 +/- 0.10 ml / min,P小于0.05),与单个肾单位相同肾小球滤过率(54 +/- 7.1对46 +/- 4.0 nl / min,P小于0.05)。两组的单肾小球传入血浆流量相当。依那普利将平均肾小球毛细血管液压从正常值51 +/- 1 mmHg(未治疗的大鼠)降低到低于正常值(44 +/- 1 mmHg,P小于0.001)。这些血液动力学变化与传入小动脉阻力(大约23%)和传出小动脉阻力(大约26%)的显着降低有关。依那普利(0.126 +/- 0.027 nl / s / mmHg)的平均超滤系数是未处理组(0.061 +/- 0.023 nl / s / mmHg)的两倍。在依那普利治疗组和未治疗组相比,研究的所有分子大小(26-64 A),右旋糖酐大分子相对于菊粉的清除率均显着降低。使用中性溶质穿过肾小球毛细血管壁的异质性多孔模型对葡聚糖的分数清除率进行理论分析,结果表明依那普利影响肾小球膜的大小选择性,均匀地减小了假想膜孔的半径。依那普利治疗还显着限制(P小于0.01)肾小球结构性病变的发展(硬化性肾小球的平均百分比为4.2 +/- 3.5%[治疗],而在治疗结束时为28 +/- 15%[未治疗]大鼠)。研究)以及肾小管间质损害。这些结果表明,依那普利在该模型中对蛋白尿和肾小球硬化发展的保护作用是由于其改善了肾小球毛细血管的大小选择性和水力渗透性的特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号